AMANDA KINCAID: Open Payments
NPI 1225672959 · BLOWING ROCK, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 40 payments from 13 companies in 2025. Trend: 2023 $897 · 2024 $982 · 2025 $771
Food & beverage: $771
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 6 | $167 |
| AstraZeneca Pharmaceuticals LP | 10 | $157 |
| Novo Nordisk Inc | 6 | $104 |
| Tris Pharma Inc | 3 | $56 |
| Astellas Pharma US Inc | 2 | $54 |
| ABBVIE INC. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Verona Pharma, Inc. | 2 | $40 |
| Lilly USA, LLC | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: VYEPTI, AIRSUPRA, Ozempic, Dyanavel XR, Veozah, CAPLYTA, Wegovy, BREZTRI.
Industry payments across NC — which companies pay providers there.
